Rajeev M. Shah

Insider Reports History

Location
Boston, MA
Signature
/s/ Thomas P. O'Neil as Attorney in Fact for Rajeev M. Shah
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rajeev M. Shah:

Company Role Class Num Shares Value Price $ Report Date Ownership
Kala Pharmaceuticals, Inc. Director Common Stock 10,894,613 $73,429,692 $6.74 17 Jun 2021 Indirect
Kala Pharmaceuticals, Inc. Director Common Stock 20,000 $134,800 $6.74 17 Jun 2021 Direct
Solid Biosciences Inc. Director, 10%+ Owner Director Stock Option (Right to Buy) 30,000 16 Jun 2021 Direct
Black Diamond Therapeutics, Inc. Director Stock Option (Right to Buy) 16,500 16 May 2023 Indirect
Satsuma Pharmaceuticals, Inc. Director, 10%+ Owner Common Stock, $0.0001 par value 0 $0.9100 06 Jun 2023 Indirect
Satsuma Pharmaceuticals, Inc. Director, 10%+ Owner Stock Option (right to buy) 0 08 Jun 2023 Direct

Insider Reports Filed by Rajeev M. Shah

Symbol Company Period Transactions Value $ Form Type Role Filing Time
STSA Satsuma Pharmaceuticals, Inc. 06 Jun 2023 4 -$5,381,969 4 Director, 10%+ Owner 08 Jun 2023, 16:45
BDTX Black Diamond Therapeutics, Inc. 16 May 2023 1 $0 4 Director 17 May 2023, 21:10
BDTX Black Diamond Therapeutics, Inc. 10 Jun 2022 1 $0 4 Director 13 Jun 2022, 19:06
BDTX Black Diamond Therapeutics, Inc. 18 Jun 2021 1 $0 4 Director 22 Jun 2021, 18:16
KALA Kala Pharmaceuticals, Inc. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 17:31
SLDB Solid Biosciences Inc. 16 Jun 2021 1 $0 4 Director, 10%+ Owner 21 Jun 2021, 16:00
BDTX Black Diamond Therapeutics, Inc. 20 May 2021 1 -$10,636 4 Director 21 May 2021, 17:52